Johnson & Johnson (JNJ) Stock Price Rises 1.44%, Is It Good Time to Buy?
As Johnson & Johnson (JNJ) stock prices rise, is the company can be still viewed as a good option for investors despite the legal issues?
JNJ Stock Up Less Than 1%, Johnson & Johnson to Make 1B Doses of COVID-19 Vaccine in 2021
By
Darya Rudz
On Friday, Johnson & Johnson (JNJ) stock closed 0.75% up at $148.70. In the pre-market today, JNJ shares are up another 0.20% up, trading at $149.00.
Johnson & Johnson (JNJ) Stock Rose 4.20% Yesterday as Experts Upgraded Ratings
Johnson & Johnson (JNJ) stock rose by 4.20% on April 9 to hit $143.26. The rise coincided with the positive ratings by different analysts like Citigroup. They believe the stock may reach $163.
Johnson & Johnson Stock Up 7%, Human Testing of Coronavirus Vaccine to Begin by September
By
Andy Watson
Johnson & Johnson after the announcement of the test of its coronavirus vaccine, JNJ stock has continued to surge, rising over 7%.